[Sinovac Reports Unaudited Second Quarter 2019 Financial Results BEIJING, China, August 15, 2019 /Business Wire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA) (“Sinovac” or the “Company”), a leading provider of biopharmaceutical products in China, announced today its unaudited financial results for the secon]
[Sinovac Reports Unaudited Second Quarter 2019 Financial Results BEIJING, China, August 15, 2019 /Business Wire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA) (“Sinovac” or the “Company”), a leading provider of biopharmaceutical products in China, announced today its unaudited financial results for the secon]
[] [LOAN AGREEMENT Party A: Zhilin Li ID Number: [XXX] Party B: Hainan Helpson Medical & Biotechnology Co., Ltd. The two parties above have reached the following agreements with regards to a loan based on equality, voluntariness and consensus. 1. Party A agrees to lend Party B a loan of RMB￥4.77 mill]
[] [LOAN AGREEMENT Party A: Zhilin Li ID Number: [XXX] Party B: Hainan Helpson Medical & Biotechnology Co., Ltd. The two parties above have reached the following agreements with regards to a loan based on equality, voluntariness and consensus. 1. Party A agrees to lend Party B a loan of RMB￥4.77 mill]
[Sinovac Reports Unaudited First Quarter 2019 Financial Results BEIJING, China, July 10, 2019 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA) (“Sinovac” or the “Company”), a leading provider of biopharmaceutical products in China, announced today its unaudited financial results for the first quart]
[Sinovac Reports Unaudited First Quarter 2019 Financial Results BEIJING, China, July 10, 2019 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA) (“Sinovac” or the “Company”), a leading provider of biopharmaceutical products in China, announced today its unaudited financial results for the first quart]
[Sinovac Reports Unaudited First Quarter 2019 Financial Results BEIJING, China, July 10, 2019 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA) (“Sinovac” or the “Company”), a leading provider of biopharmaceutical products in China, announced today its unaudited financial results for the first quart]
[Sinovac Reports Unaudited First Quarter 2019 Financial Results BEIJING, China, July 10, 2019 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA) (“Sinovac” or the “Company”), a leading provider of biopharmaceutical products in China, announced today its unaudited financial results for the first quart]
